about
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, No...
Read More
1.66
0.01
(0.61%)
4.6M
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Ocugen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..